Cargando…

The changing landscape of automated insulin delivery in the management of type 1 diabetes

Automated insulin delivery systems, also known as closed-loop or ‘artificial pancreas’ systems, are transforming the management of type 1 diabetes. These systems consist of an algorithm which responds to real-time glucose sensor levels by automatically modulating insulin delivery through an insulin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lakshman, Rama, Boughton, Charlotte, Hovorka, Roman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448576/ https://www.ncbi.nlm.nih.gov/pubmed/37289734 http://dx.doi.org/10.1530/EC-23-0132

Ejemplares similares

New closed-loop insulin systems
por: Boughton, Charlotte K., et al.
Publicado: (2021)

Fully automated closed-loop insulin delivery in adults with type 2 diabetes: an open-label, single-center, randomized crossover trial
por: Daly, Aideen B., et al.
Publicado: (2023)

Closed-loop insulin delivery for treatment of type 1 diabetes
por: Elleri, Daniela, et al.
Publicado: (2011)

Insulin delivery and nocturnal glucose control in children and adolescents with type 1 diabetes
por: Tauschmann, Martin, et al.
Publicado: (2017)

Can exenatide flatten the post-prandial glucose curve in type 1 diabetes?
por: Boughton, Charlotte K., et al.
Publicado: (2020)

Correction to: New closed-loop insulin systems
por: Boughton, Charlotte K., et al.
Publicado: (2021)

Fully automated closed-loop glucose control compared with standard insulin therapy in adults with type 2 diabetes requiring dialysis: an open-label, randomized crossover trial
por: Boughton, Charlotte K., et al.
Publicado: (2021)

Publisher Correction: Fully automated closed-loop glucose control compared with standard insulin therapy in adults with type 2 diabetes requiring dialysis: an open-label, randomized crossover trial
por: Boughton, Charlotte K., et al.
Publicado: (2021)

Modelling endogenous insulin concentration in type 2 diabetes during closed-loop insulin delivery
por: Ruan, Yue, et al.
Publicado: (2015)

Impact of the CamAPS FX hybrid closed‐loop insulin delivery system on sleep traits in older adults with type 1 diabetes
por: Thabit, Hood, et al.
Publicado: (2022)

Closed-loop management of inpatient hyperglycemia
por: Boughton, Charlotte K., et al.
Publicado: (2019)

Feasibility of automated insulin delivery guided by continuous glucose monitoring in preterm infants
por: Beardsall, Kathryn, et al.
Publicado: (2020)

Closed-Loop Insulin Delivery During Pregnancy Complicated by Type 1 Diabetes
por: Murphy, Helen R., et al.
Publicado: (2011)

Coming of age: the artificial pancreas for type 1 diabetes
por: Thabit, Hood, et al.
Publicado: (2016)

Assessing the efficacy, safety and utility of 6-month day-and-night automated closed-loop insulin delivery under free-living conditions compared with insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, multicentre, multinational, single-period, randomised, parallel group study protocol
por: Musolino, Gianluca, et al.
Publicado: (2019)

Closed‐loop insulin delivery in end‐of‐life care: a case report
por: Boughton, C. K., et al.
Publicado: (2019)

The Psychological Implications of Automated Insulin Delivery Systems in Type 1 Diabetes Care
por: Nefs, Giesje
Publicado: (2022)

Assessment of Meal Anticipation for Improving Fully Automated Insulin Delivery in Adults With Type 1 Diabetes
por: Garcia-Tirado, Jose, et al.
Publicado: (2023)

Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice
por: Phillip, Moshe, et al.
Publicado: (2022)

Parents’ experiences of caring for a young child with type 1 diabetes: a systematic review and synthesis of qualitative evidence
por: Kimbell, B., et al.
Publicado: (2021)

Automated Insulin Delivery with SGLT2i Combination Therapy in Type 1 Diabetes
por: Garcia-Tirado, Jose, et al.
Publicado: (2022)

AiDAPT: automated insulin delivery amongst pregnant women with type 1 diabetes: a multicentre randomized controlled trial – study protocol
por: Lee, Tara T. M., et al.
Publicado: (2022)

Technology in the management of type 2 diabetes – present status and future prospects
por: Daly, Aideen, et al.
Publicado: (2021)

Insulin Administration and Rate of Glucose Appearance in People With Type 1 Diabetes
por: Pennant, Mary E., et al.
Publicado: (2008)

Fully closed-loop insulin delivery in inpatients receiving nutritional support: a two-centre, open-label, randomised controlled trial
por: Boughton, Charlotte K, et al.
Publicado: (2019)

Assessing the effect of closed-loop insulin delivery from onset of type 1 diabetes in youth on residual beta-cell function compared to standard insulin therapy (CLOuD study): a randomised parallel study protocol
por: Boughton, Charlotte, et al.
Publicado: (2020)

Automated Insulin Delivery (AID) Systems: Use and Efficacy in Children and Adults with Type 1 Diabetes and Other Forms of Diabetes in Europe in Early 2023
por: Bassi, Marta, et al.
Publicado: (2023)

Zone-MPC Automated Insulin Delivery Algorithm Tuned for Pregnancy Complicated by Type 1 Diabetes
por: Ozaslan, Basak, et al.
Publicado: (2022)

Review of Automated Insulin Delivery Systems for Type 1 Diabetes and Associated Time in Range Outcomes
por: Nallicheri, Armaan, et al.
Publicado: (2022)

Practical Aspects and Exercise Safety Benefits of Automated Insulin Delivery Systems in Type 1 Diabetes
por: Zaharieva, Dessi P., et al.
Publicado: (2023)

Insulin-delivery methods for children and adolescents with type 1 diabetes
por: Zuberi, Zavuga, et al.
Publicado: (2020)

Pharmacokinetics of diluted (U20) insulin aspart compared with standard (U100) in children aged 3–6 years with type 1 diabetes during closed-loop insulin delivery: a randomised clinical trial
por: Ruan, Yue, et al.
Publicado: (2014)

Cost-effectiveness of the tubeless automated insulin delivery system vs standard of care in the management of type 1 diabetes in the United States
por: Biskupiak, Joseph E, et al.
Publicado: (2023)

Closed-Loop Basal Insulin Delivery Over 36 Hours in Adolescents With Type 1 Diabetes: Randomized clinical trial
por: Elleri, Daniela, et al.
Publicado: (2013)

Hypoglycaemia incidence and recovery during home use of hybrid closed‐loop insulin delivery in adults with type 1 diabetes
por: Ruan, Yue, et al.
Publicado: (2018)

Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies
por: Hovorka, Roman, et al.
Publicado: (2011)

Hybrid Closed-loop to Manage Gastroparesis in People With Type 1 Diabetes: a Case Series
por: Daly, Aideen, et al.
Publicado: (2021)

Faster insulin action is associated with improved glycaemic outcomes during closed‐loop insulin delivery and sensor‐augmented pump therapy in adults with type 1 diabetes
por: Ruan, Yue, et al.
Publicado: (2017)

Continuous Glucose Monitor, Insulin Pump, and Automated Insulin Delivery Therapies for Type 1 Diabetes: An Update on Potential for Cardiovascular Benefits
por: Pauley, Meghan E., et al.
Publicado: (2022)

Training and Support for Hybrid Closed-Loop Therapy
por: Boughton, Charlotte K., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_eqmgm4vj5c8pqe9f3t490o2ns4